Novartis India Cash Flow Annual

Trade
BSE: 500672 | NSE: NOVARTIND | ISIN: INE234A01025 | Sector: Biotechnology & Drugs
1,028.20 +2.40 (0.23%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 122.84115.38-3.8240.04
Depreciation/ Depletion 2.616.069.6512.16
Non- Cash Items -59.36-54.98-15.29-17.14
Changesin Working Capital 47.31-21.6648.13-104.27
Cashfrom Operating Activities 113.4044.8038.67-69.21
Capital Expenditures 0.00-0.31-0.50-0.09
Other Investing Cash Flow Items Total 33.13-152.9487.5495.25
Cashfrom Investing Activities 33.13-153.2587.0495.16
Financing Cash Flow Items -0.01-0.05-0.04-6.54
Total Cash Dividends Paid -117.28-24.69-24.69-24.69
Issuance( Retirement)of Debt Net -3.70-5.74-10.90-5.57
Cashfrom Financing Activities -120.99-30.48-35.63-36.80
Net Changein Cash 25.54-138.9390.08-10.85
Cash Interest Paid 0.010.050.046.54
Cash Taxes Paid -38.27-2.3418.5935.19
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts